Innate Pharma SA Adjustments For Decrease Increase In Trade And Other Receivables
Innate Pharma SA (IPHA) reported Adjustments For Decrease Increase In Trade And Other Receivables of EUR 1.65 million for the 12-month period ending 2025-12-31, per its 20-F filed 2026-04-01.
Financial Statements › Notes › Receivables
ifrs-full:AdjustmentsForDecreaseIncreaseInTradeAndOtherReceivables · last filed 2026-04-01
| Period end | Adjustments For Decrease Increase In Trade And Other Receivables 6 month | Adjustments For Decrease Increase In Trade And Other Receivables 12 month |
|---|---|---|
| 2025-12-31 | 1.65M EUR 20-F · filed 2026-04-01 | |
| 2025-06-30 | -2.69M EUR 6-K · filed 2025-09-17 | |
| 2024-12-31 | 51.81M EUR 20-F · filed 2026-04-01 | |
| 2024-06-30 | 31.84M EUR 6-K · filed 2025-09-17 | |
| 2023-12-31 | -13.67M EUR 20-F · filed 2025-04-30 | |
| 2023-06-30 | -4.00M EUR 6-K · filed 2024-09-12 | |
| 2022-12-31 | -4.20M EUR 20-F · filed 2024-04-04 | |
| 2022-06-30 | -13.29M EUR 6-K · filed 2023-09-14 | |
| 2021-12-31 | 3.39M EUR 20-F · filed 2023-04-06 | |
| 2021-06-30 | 6.51M EUR 6-K · filed 2022-09-15 | |
| 2020-12-31 | -22.92M EUR 20-F · filed 2022-04-04 | |
| 2020-06-30 | -10.68M EUR 6-K · filed 2021-09-15 | |
| 2019-12-31 | 110.30M EUR 20-F · filed 2021-04-27 | |
| 2018-12-31 | 110.30M EUR 20-F · filed 2020-04-24 |